GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
TableEdit
PMID:20209097
You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki
See Help for Help on this wiki. See the documentation for how to use the table editor
Citation |
Mengshol, JA, Golden-Mason, L, Arikawa, T, Smith, M, Niki, T, McWilliams, R, Randall, JA, McMahan, R, Zimmerman, MA, Rangachari, M, Dobrinskikh, E, Busson, P, Polyak, SJ, Hirashima, M and Rosen, HR (2010) A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS ONE 5:e9504 |
---|---|
Abstract |
Approximately 200 million people throughout the world are infected with hepatitis C virus (HCV). One of the most striking features of HCV infection is its high propensity to establish persistence (approximately 70-80%) and progressive liver injury. Galectins are evolutionarily conserved glycan-binding proteins with diverse roles in innate and adaptive immune responses. Here, we demonstrate that galectin-9, the natural ligand for the T cell immunoglobulin domain and mucin domain protein 3 (Tim-3), circulates at very high levels in the serum and its hepatic expression (particularly on Kupffer cells) is significantly increased in patients with chronic HCV as compared to normal controls. Galectin-9 production from monocytes and macrophages is induced by IFN-gamma, which has been shown to be elevated in chronic HCV infection. In turn, galectin-9 induces pro-inflammatory cytokines in liver-derived and peripheral mononuclear cells; galectin-9 also induces anti-inflammatory cytokines from peripheral but not hepatic mononuclear cells. Galectin-9 results in expansion of CD4(+)CD25(+)FoxP3(+)CD127(low) regulatory T cells, contraction of CD4(+) effector T cells, and apoptosis of HCV-specific CTLs. In conclusion, galectin-9 production by Kupffer cells links the innate and adaptive immune response, providing a potential novel immunotherapeutic target in this common viral infection. |
Links |
PubMed PMC2831996 Online version:10.1371/journal.pone.0009504 |
Keywords |
CD4 Antigens/biosynthesis; CD4-Positive T-Lymphocytes/metabolism; CD4-Positive T-Lymphocytes/virology; Forkhead Transcription Factors/biosynthesis; Galectins/metabolism; Gene Expression Regulation, Viral; Hepacivirus/metabolism; Hepatitis C/metabolism; Humans; Immunotherapy/methods; Interferon-gamma/metabolism; Interleukin-2 Receptor alpha Subunit/biosynthesis; Interleukin-7 Receptor alpha Subunit/biosynthesis; Kupffer Cells/metabolism; Leukocytes, Mononuclear/cytology; Ligands; Macrophages/metabolism; Monocytes/metabolism; T-Lymphocytes/immunology |
public |
Cancel |